Perturbations in nuclear factor-κB or c-Jun N-terminal kinase pathways in pancreatic beta cells confer susceptibility to cytokine-induced cell death

被引:19
|
作者
Thomas, HE [1 ]
Angstetra, E [1 ]
Fernandes, RV [1 ]
Mariana, L [1 ]
Irawaty, W [1 ]
Jamieson, EL [1 ]
Dudek, NL [1 ]
Kay, TW [1 ]
机构
[1] St Vincents Inst Med Res, Melbourne, Vic, Australia
来源
IMMUNOLOGY AND CELL BIOLOGY | 2006年 / 84卷 / 01期
关键词
apoptosis; cytokine; nitric oxide; nuclear factor-kappa B; type 1 diabetes mellitus;
D O I
10.1111/j.1440-1711.2005.01397.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Pro-inflammatory cytokines have been implicated in the death of pancreatic beta cells leading to type 1 diabetes. NIT-1 cells are an insulinoma cell line derived from mice expressing the SV40 large T antigen. These cells are a useful tool in analysis of beta cell death. NIT-1 cells are highly susceptible to caspase-dependent apoptosis induced by TNF-alpha alone. Primary islets are not susceptible to cell death induced by TNF-alpha alone; however, they are killed by TNF-alpha and IFN-gamma in a nitric oxide-dependent manner. We examined signal transduction in NIT-1 cells in response to cytokines to determine the mechanism for TNF-alpha-induced apoptosis. We found that NIT-1 cells are defective in the activation of nuclear factor-kappa B (NF kappa B) as a result of functionally deficient RelA activity, because overexpression of RelA protected NIT-1 cells from apoptosis. TNF-alpha also did not induce phosphorylation of c-Jun N-terminal kinase in NIT-1 cells. Together, these defects prevent expression of anti-apoptotic genes in NIT-1 cells and make them susceptible to TNF-alpha. To determine whether similar defects in primary beta cells would induce the same effect, we examined TNF-alpha-induced apoptosis in islets isolated from mice deficient in NF kappa B p50. These islets were as susceptible as wild-type islets to TNF-alpha and IFN-gamma-induced cell death. In contrast to wild-type islets, cell death was not prevented by inhibition of nitric oxide in p50-deficient islets. Blocking NF kappa B has been proposed as a mechanism for protection of beta cells from cytokine-induced cell death in vivo. Our results suggest that this would make beta cells equally or more sensitive to cytokines.
引用
收藏
页码:20 / 27
页数:8
相关论文
共 50 条
  • [1] MAPK kinase kinase-1 is essential for cytokine-induced c-Jun NH2-terminal kinase and nuclear factor-κB activation in human pancreatic islet cells
    Mokhtari, Dariush
    Myers, Jason W.
    Welsh, Nils
    DIABETES, 2008, 57 (07) : 1896 - 1904
  • [2] Rosuvastatin suppresses the inflammatory responses through inhibition of c-jun N-terminal kinase and nuclear factor-κB in endothelial cells
    Kim, Yong Sook
    Ahn, Youngkeun
    Hong, Moon Hwa
    Kim, Kye Hun
    Park, Hyung Wook
    Hong, Young Joon
    Kim, Ju Han
    Kim, Weon
    Jeong, Myung Ho
    Cho, Jeong Gwan
    Park, Jong Chun
    Kang, Jung Chaee
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (06) : 376 - 383
  • [3] Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways
    Lee, Kyong Joo
    Jang, Yoon Ok
    Cha, Seung-Kuy
    Kim, Moon Young
    Park, Kyu-Sang
    Eom, Young Woo
    Baik, Soon Koo
    GUT AND LIVER, 2018, 12 (04) : 449 - +
  • [4] VEGI, a new member of the TNF family activates Nuclear Factor-κB and c-Jun N-terminal kinase and modulates cell growth
    Valsala Haridas
    Anju Shrivastava
    Jeffrey Su
    Guo-Liang Yu
    Jian Ni
    Ding Liu
    Su-Fang Chen
    Yansong Ni
    Steve M Ruben
    Reiner Gentz
    Bharat B Aggarwal
    Oncogene, 1999, 18 : 6496 - 6504
  • [5] VEGI, a new member of the TNF family activates Nuclear Factor-κB and c-Jun N-terminal kinase and modulates cell growth
    Haridas, V
    Shrivastava, A
    Su, J
    Yu, GL
    Ni, J
    Liu, D
    Chen, SF
    Ni, YS
    Ruben, SM
    Gentz, R
    Aggarwal, BB
    ONCOGENE, 1999, 18 (47) : 6496 - 6504
  • [6] Requirement of c-Jun N-terminal kinase for apoptotic cell death induced by farnesyltransferase inhibitor, farnesylamine, in human pancreatic cancer cells
    Mizukami, Y
    Ura, H
    Obara, T
    Habiro, A
    Izawa, T
    Osanai, M
    Yanagawa, N
    Tanno, S
    Kohgo, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (01) : 198 - 204
  • [7] Regulation of Multidrug Resistance Protein 1 by Tumor Necrosis Factor α in Cultured Glial Cells: Involvement of Nuclear Factor-κB and c-Jun N-Terminal Kinase Signaling Pathways
    Ronaldson, Patrick T.
    Ashraf, Tamima
    Bendayan, Reina
    MOLECULAR PHARMACOLOGY, 2010, 77 (04) : 644 - 659
  • [8] Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-κB signaling
    Littlejohn, AF
    Tucker, SJ
    Mohamed, AAA
    McKay, S
    Helms, MJ
    Vandenabeele, P
    MacEwan, DJ
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (01) : 91 - 99
  • [9] A Combined "Omics" Approach Identifies N-Myc Interactor as a Novel Cytokine-induced Regulator of IRE1α Protein and c-Jun N-terminal Kinase in Pancreatic Beta Cells
    Brozzi, Flora
    Gerlo, Sarah
    Grieco, Fabio Arturo
    Nardelli, Tarlliza Romanna
    Lievens, Sam
    Gysemans, Conny
    Marselli, Lorella
    Marchetti, Piero
    Mathieu, Chantal
    Tavernier, Jan
    Eizirik, Decio L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (30) : 20677 - 20693